Clinical trial
A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who…
NCT00210977 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Withdrawn
Key facts
| NCT number | NCT00210977 |
|---|---|
| Title | A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies |
| Official title | An Observational Study of Subjects Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | No intervention |
| Enrollment | 0 |
| Start date | Dec 1, 2005 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 2, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: